vTv Therapeutics (VTVT) Return on Invested Capital (2015 - 2017)

vTv Therapeutics (VTVT) posted Return on Invested Capital of 0.02% for Q4 2017, down 91.71% sequentially from 0.01% in Q3 2017.

vTv Therapeutics (VTVT) Return on Invested Capital (2015 - 2017) Analysis & Trends

vTv Therapeutics has reported Return on Invested Capital for 3 years, with the latest figure at 0.02% in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.04%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.00%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -0.05%
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.35%
10 vTv Therapeutics 373.77 Mn 373.77 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2017 -0.02%
Sep 30, 2017 -0.01%
Jun 30, 2017 -0.01%
Mar 31, 2017 -0.02%
Mar 31, 2016 -0.01%
Dec 31, 2015 -0.01%